(MoneyNewsWire.Net, August 24, 2017 ) The Middle-East and Africa Blood Testing Market was worth $4.22 billion in 2016 and estimated to be growing at a CAGR of 2.69%, to reach $4.83 billion by 2021.
Blood Testing Market Growth is a laboratory based examination that is performed in direct to conclude general state of health, occurrence of a bacteria or virus and to consider disease progression. It is usually performed by taking a small sample of blood from the patient’s body with the help of a needle or finger prick.
View Full Report @ http://www.marketdataforecast.com/market-reports/middle-east-and-africa-blood-testing-market-1410/
Shift in focus of healthcare providers from treatment towards early exposure of diseases, particularly in fields of cardiovascular and endocrinology medicine, has poised the industry to observe lucrative growth during the forecast period. Other notable drivers include the introduction of various innovative solutions that enable faster and accurate diagnosis by using plasma or serum screening methods. Restraints for the market include high cost of advanced blood culture techniques and lack of appropriate reimbursement policies.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/middle-east-and-africa-blood-testing-market-1410/request-sample
The Middle-East and Africa blood testing market is segmented on the basis of type into Complete Blood Count, Blood Chemistry Tests, Blood Enzymes Tests and Blood Clotting Tests. Complete Blood Count segmented is further divided into Red Blood Cells, White Blood Cells, Haemoglobin, Hematocrit and Platelets. Blood Chemistry Tests are bifurcated among Test for Electrolytes, Blood Glucose, Calcium and Test for Kidney Function. Blood Enzymes Tests are sub segmented into Troponin and Creatine Kinase.
Blood Clotting Tests Segment is segregated among Prothrombin time and Activated Partial Thromboplastin time and Blood Coagulation. On the basis of diseases the market is divided into Anaemia, Infection, Leukaemia, Hypokalemia, Kidney Disorders, Heart Attack and Coronary Heart Disease. Based on Methods, market is bifurcated among Manual Blood Culture Testing and Automated Blood Culture Testing. Automated Blood Culture Testing division is further sub segmented into Automated Blood Culture System and Blood Culture Instruments.
Inquire before Buying @ http://www.marketdataforecast.com/market-reports/middle-east-and-africa-blood-testing-market-1410/inquire
Based on geography the Middle-East and Africa market is analysed under various countries Middle-East and Africa. Africa is leading the blood testing market and Middle-East is estimated to grow at highest CAGR in the forecast period.
Major players in this market are Bio-Rad Laboratories Inc. (U.S.), Siemens Healthcare (Germany), Grifols (Spain), Nanosphere Inc. (U.S.), BioMérieux (France), Dickinson and Company (U.S.), Ortho Clinical Diagnostics Inc. (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Bruker Corporation (U.S.), Abbott Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.) and Beckman Coulter (U.S.).
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com
|